{"name":"Chimeric Therapeutics","slug":"chimeric-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxQN0RlczhJa0xfZ3lZR185VC1qMGl4SW1vMGJvRGsweThMZER1YWdaekQtMTBEYmt3WUYzZ1ZLYXVKQnVudG9Jd0VZOG9yLTY0Zi0yQmNFNGhXLUxyYUFPY3NGc1ppM1dXRGRZdGNHbVlvZjJXemdSbjc0OFhvaEE2QjRNT3RCYkpjUEdUbFRuOVFOand3NXhQZ2FieVJQRDJHLTVVLWtySnFwYUFBdDBKaldrR3RGd1ctQWs1NkRNOHhBWGwxbnRtNTNn?oc=5","date":"2026-02-17","type":"pipeline","source":"Biotech Dispatch","summary":"Chimeric Therapeutics names experienced biotech leader as chair in board and executive refresh - Biotech Dispatch","headline":"Chimeric Therapeutics names experienced biotech leader as chair in board and executive refresh","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxPSFpnTjJwRHBCZUpyMlRELUtIbnA1RlQ3dkhGcUtpdHpLV3hVRkg3RHFjQWJYQnc5a1d0al84cFZzcjRQZXN6SjY0cDA4Z0d3QVFFRjBQVjNlUXdLVFJpT0s5ZnhTaXNpU3RpM1RFVnhSR0Flc2ZUZDRNV0Y0emNyYtIBlAFBVV95cUxOVDU1NHhtUDBsU0JtbzBuNlhuNkxpUHd0VkI1Rmg3R0k1TWJySHpmWWFaRU9wd2w2b1h6UXZZbXBWQ3p0NWlscUhTQWlPeFc0b20wNTF4Q0VMSVEwa2lpWURSY3l6QlVqZlV0dE1TeUpMTWI3X1gyY1R2TVgxTHJzUUxBNUxlSlh1LVE1am16S1hWU0RU?oc=5","date":"2026-02-11","type":"pipeline","source":"Chosunbiz","summary":"In vivo CAR-T draws big-pharma bets as Korea players race to market - CHOSUNBIZ - Chosunbiz","headline":"In vivo CAR-T draws big-pharma bets as Korea players race to market - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxQSDBXZ243SnRELU9tTG5VZTBBaUFIQkVwVmJEYW42OGc5emVxOWVhSGlZcng5U1RDZE5IWUM5YUdYRE1VSDBpVFZxTW5iNUF0X29DSUlDa3RBaHpKRmhwODNuU1hlRmEyQzNDLU9VUlVYN29vb3dTZFl1T21FU2FWNXpGZklzS2hZQXNoV21KczXSAZYBQVVfeXFMTmdVSG5xdU5Qa2JKdFpoQWYyaHhkUkxfM1FUdmljWjc5Z2VZYkxxRzhsa0VmZWZXc2h1UWY4MFFibXlwbXplT0VBS2dITk5ya1oxVlRwN3JJUF9fOFkwQlZ5eHB1NmNwRWZQV0NvMVlmSDZka3laZlZTMjNaN1FXdWxiU0hUSC1XckpWb09qRGNVSDI3UXdR?oc=5","date":"2026-01-17","type":"pipeline","source":"BioInformant","summary":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide - BioInformant","headline":"CAR-T Cell Companies Proliferate: List of CAR-T Companies Worldwide","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8gFBVV95cUxPYlJIRE1DMFhSeXZ1YXo3Mno2MmpPVHZCWHA1cW1BZEJBbFZyS0tmTWJ0NlpmaU5QbVNsZHNvaFNmR0NvbThjZEFhMWYzSkQ5TWswMFk3bnB2akVaRnJYNmFNaGh3bUpLUEFrZDZIY1V1Z0xyei0ydnVLYnFEV3gyR3VSTllzLWJHUlk3UUw2eGtjNDRiemoycFVpdVZVVnRWRXh4bXNEVGxYU3l1UlBJczZpcTJkU0VDT0w1NWJqaFlxVXFLWTE3cWItZHVXQjFWb0tvMmlnX1AtY0xMbjRta3FHTlNFd1lRLUY1T1hPQkJ6dw?oc=5","date":"2025-12-07","type":"regulatory","source":"Proactive financial news","summary":"Chimeric Therapeutics secures FDA Orphan Drug Designation for CHM CDH17 in gastric cancer - Proactive financial news","headline":"Chimeric Therapeutics secures FDA Orphan Drug Designation for CHM CDH17 in gastric cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2AFBVV95cUxOYzAtZHRDa2EwWE85U2ZXa2NkWUlYY1dUT0NKUUltOXBQdVRnUnVWVEVJYURaUVVnUUZCSnItU2YxWUJpZzRDRm9ONjlNVDdnQkxnbFEzNmFNT2ZqZEZCaEJXalFTeG9NbWlrNDBFeDBCQnFLYUYxQ3ZOQVBhTWRlUlptSFhaQWVyU1lGbU91dDdDMkdNckIwNkRjd1hua05TeG1WMU5DdGNtbjhTazd3T0ItV3dRRGpqdHcxT19XWjVNY0JJZDAzYk84TGpmbUFYYVdGb1ZvLWk?oc=5","date":"2025-11-24","type":"pipeline","source":"Proactive financial news","summary":"Chimeric Therapeutics receives $4.5 million R&D tax incentive refund | ASX:CHM, OTC:CHMMF - Proactive financial news","headline":"Chimeric Therapeutics receives $4.5 million R&D tax incentive refund | ASX:CHM, OTC:CHMMF","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQTmJLUkI4VzZOTXN3aTlIODhUZjlGMURjSW45YzVUbmhjNy1CbEFpOXY4Nk16dkdaLUR6cnU1YjJiSkE2eGRiblFVNlZyNkJ5Z1gxY1JVczdyaDNfZ3lzYVJpdW91TXo0VEpqSlZJb3JxemZzUGFXdkJvNFo1cjJZYTJHelo1UVRWYV9FMzY0aHpvenVRbDBzYjBJRHVKdHpwb3hHdGxKSlJIRGZOQU1UUXBGN05mZkE2R0E?oc=5","date":"2025-11-17","type":"pipeline","source":"Forbes Australia","summary":"The Australian biotechs racing toward the next billion-dollar cancer drug - Forbes Australia","headline":"The Australian biotechs racing toward the next billion-dollar cancer drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE02VHhGeURiNWs2cTNrOVJZR1hGUVJpU3VCMVRvRkhPQUl1V1BwaDl3UThEZWxWNklLSnVaNlBSMTdpZ1hLRE8wR1BHb0NWekNI?oc=5","date":"2025-10-30","type":"pipeline","source":"smallcaps.com.au","summary":"Insights: Chimeric Therapeutics Ltd (ASX:CHM) - smallcaps.com.au","headline":"Insights: Chimeric Therapeutics Ltd (ASX:CHM)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQQVI2Xy05UlBYclEtSUZjZUtEbGp1U2w4U1BZZUQydFllZmtKZjg3S2d2S2w0TnVXMW1icEotRlZEeUt0bW81TENUMlJ3RzFqamZPclN2cW1vOHQ2UGhoYlNMa2tlaEZxVFR6VEExcnJSN3NGdjBCeTl4X0ozQjVOU0o4OEd6Q28xNDdxNDZ1WDh4eTdNdV84YWFobkc2RmJMMFpXZGtQb3U4d3l2ODh5S3kxNGZBRWFhbjVhTEZJZ0g?oc=5","date":"2025-06-30","type":"regulatory","source":"TechTarget","summary":"FDA removes REMS for all autologous CAR T-cell immunotherapies - TechTarget","headline":"FDA removes REMS for all autologous CAR T-cell immunotherapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxOLTNGclp3R1k1Ql95djVkdTRCRG1mbmlmSDhFTm52MlJGZjdaNG9qU1VfbWxyUUVoOWs3aUJvUUY2M3o4bEtfUExtVXNOY1F0MUU3MzRWbFRSYmZMb0V2eEJuUnNTU1cxQUVFbXZieW1TQmxXRWxuUDRtZlM2allWeUpNQlVvN0gyNHNaSE9CTjQ0TE84ZTJJT0tlSlQtX0FCQWNqMXdhMElMa1lRdDgtZDRRNU84U1otT2ZCbXdEekttb3FKSFNZbnIxRndueUw4S0d4OTR5V3BpNkV0dTNTRzVMM2oxVGxrd1p3TFZCZmNpdXIyZGJkWm1xOW83aDM0UFV2WUM3cTdWOHVrUDg2VHJqcC1YNmxmbWl4VmlhNjlKYkZHMXc?oc=5","date":"2024-11-11","type":"trial","source":"prnewswire.com","summary":"NK Cell Therapy Clinical Trial Pipeline Appears Robust With 140+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - prnewswire.com","headline":"NK Cell Therapy Clinical Trial Pipeline Appears Robust With 140+ Key Pharma Companies Actively Working in the Therapeuti","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihwFBVV95cUxPbGI1V1ZBeUlqM0JQM0ZwZmZuUzItRFRQaXZHWWVLdGQ3d0w1ZVl6VURZZFFOVmktd1p1cXpYQjlpcHpWTDhmd1phc0tjTXAzS0xNeUVhQzVxWThNRTFmaDJXcnp1LXRxSEwtbFoyV3JoX0lNS1c4Sm02eUljTXMwN0xXR0hULWM?oc=5","date":"2023-06-05","type":"trial","source":"Clinical Trials Arena","summary":"Chimeric launches Phase IB trial of glioblastoma multiforme therapy - Clinical Trials Arena","headline":"Chimeric launches Phase IB trial of glioblastoma multiforme therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxQam1KbmhxYWJFVVVvRmhBSDZXaURGZklkUkpRa1lmdVBfRmNwVmpvdTFDeWZscEZfcXhiUFNJU3JRNmplZVdVMThQT2Vadm1oaEFwVWg2cDY3TjNnUjBMTzFSRzNKSjQ1dkpIRUtXTzFuekxPOVYtWkhnYk9uVTBuUmVTWUZtSmFpRGFoekNDMU9sWXlxRnRQMVNZcC1iV3RadVRIM3NtNnhqT0RKYjhxTmJtX21PQVNIbTNNTk03WjQ?oc=5","date":"2023-01-05","type":"pipeline","source":"Pharmaceutical Technology","summary":"Innovation in immuno-oncology: Leading companies in cancer chimeric antigen receptor (CAR) T-cell therapy - Pharmaceutical Technology","headline":"Innovation in immuno-oncology: Leading companies in cancer chimeric antigen receptor (CAR) T-cell therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE1vbko5Zy13emVaV2VHajNKYjF1WVVCWVA3TFJvYUJlUC1kQ1lwdUZSYmhvUE1IWUtQaUh2Rk5zT0U2TUxkd1ZjR1d1V096R1RQYUlLdXFmWQ?oc=5","date":"2022-09-21","type":"pipeline","source":"ASCO Publications","summary":"Chimeric Antigen Receptor T-Cell Therapies: Barriers and Solutions to Access - ASCO Publications","headline":"Chimeric Antigen Receptor T-Cell Therapies: Barriers and Solutions to Access","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}